Skip to main content
. Author manuscript; available in PMC: 2019 May 15.
Published in final edited form as: Life Sci. 2018 Mar 21;201:63–71. doi: 10.1016/j.lfs.2018.03.041

Figure 7. Inhibition of Akt1 and 4E-BP1 in pBOO bladder by LY294002 treatment.

Figure 7

LY294002 (LY) treatment reduces the phosphorylation levels of Akt1 (A-B) and 4E-BP1 (C-D) in pBOO bladder when compared to those in vehicle-treated pBOO bladder (#, p<0.05). Vehicle treatment does not affect the up-regulation of the phosphorylation levels of Akt1 (A-B) and 4E-BP1 (C-D) caused by pBOO when compared to vehicle-treated sham control (*, p<0.05).